Synthesis and antihypertensive activity of 4-(diazabicyclo[4.1.0]-heptenyloxy)benzopyran derivatives and their analogues

Chem Pharm Bull (Tokyo). 1998 Apr;46(4):602-9. doi: 10.1248/cpb.46.602.

Abstract

A series of 3,4-dihydro-3-hydroxy-4-[(5-oxo-3,4-diazabicyclo[4.1.0]hept- 2-en-2-yl)oxy]-2H-1-benzopyrans and their analogues were synthesized and evaluated on potassium channel opening and hypotensive activities. Compound (-)-13B with a (4-methyl-5-oxo-3,4-diazabicyclo[4.1.0]hept-2-en-2-yl)oxy group for the 4-position of the benzopyran ring was 3 times as potent as EMD 57283 (II), the lead compound, in hypotensive activity. The results would demonstrate that 5-oxo-3,4-diazabicyclo[4.1.0]hept-2-en-2-yloxy moieties are effective as the substituents at the 4-position of benzopyran-type potassium channel openers.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Antihypertensive Agents / chemical synthesis*
  • Antihypertensive Agents / pharmacology
  • Benzopyrans / chemical synthesis*
  • Benzopyrans / pharmacology
  • Blood Pressure / drug effects
  • Bridged Bicyclo Compounds / chemical synthesis*
  • Bridged Bicyclo Compounds / pharmacology
  • Chromatography, High Pressure Liquid
  • Cromakalim / pharmacology
  • Crystallography, X-Ray
  • Heart Rate / drug effects
  • In Vitro Techniques
  • Male
  • Potassium Channels / drug effects*
  • Pyridazines / chemical synthesis*
  • Pyridazines / pharmacology
  • Rats
  • Rats, Inbred SHR
  • Rats, Wistar
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • Antihypertensive Agents
  • Benzopyrans
  • Bridged Bicyclo Compounds
  • EMD 57283
  • Potassium Channels
  • Pyridazines
  • Cromakalim